Skip to main content

Table 5 One-way sensitivity analysis on the ICERs (as expressed in dollars per patient maintained in target range)

From: The cost-effectiveness of point of care testing in a general practice setting: results from a randomised controlled trial

Test

Selected variables

Cost per patient maintained in target range

INR

Base ICER

Dominated*

 

GP consultations - Upper 95% CI

Dominated*

 

GP consultations - Lower 95% CI

Dominated*

 

Hospital admissions - Upper 95% CI

Dominated*

 

Hospital admissions - Lower 95% CI

SW Quadrant**

HbA1c

Base ICER

$40

 

GP consultations - Upper 95% CI

$1,049

 

GP consultations - Lower 95% CI

Dominant***

 

Hospital admissions - Upper 95% CI

$8,579

 

Hospital admissions - Lower 95% CI

Dominant***

ACR

Base ICER

Dominant***

 

GP consultations - Upper 95% CI

Dominant***

 

GP consultations - Lower 95% CI

Dominant***

 

Hospital admissions - Upper 95% CI

$17,647

 

Hospital admissions - Lower 95% CI

Dominant***

Lipids

Base ICER

$10,082

 

GP consultations - Upper 95% CI

$11,691

 

GP consultations - Lower 95% CI

$8,618

 

Hospital admissions - Upper 95% CI

$26,120

 

Hospital admissions - Lower 95% CI

Dominant***

  1. * Dominated: PoCT was more costly and less effective than laboratory testing
  2. ** SW Quadrant: PoCT was less costly and less effective than laboratory testing
  3. ***Dominant: PoCT was less costly and more effective than laboratory testing
  4. Note: this analysis was undertaken on all the other variables (consumables, tests, emergency department visits, specialist consultations and pharmaceuticals) but did not have an influence on the ICERs ie change the quadrant.